|
GS135589: P. chabaudi malaria resistance QTL 2 (Char2, Published QTL Chr 8)
|
|
GS197282: GO:0030203 glycosaminoglycan metabolic process
|
|
GS204629: GO:1901564 organonitrogen compound metabolic process
|
|
GS172195: HP:0000504 Abnormality of vision
|
|
GS175976: HP:0003621 Juvenile onset
|
|
GS136137: lithogenic gene 18 (Lith18, Published QTL Chr 8)
|
|
GS180489: GO:0030203 glycosaminoglycan metabolic process
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS175272: HP:0200020 Corneal erosions
|
|
GS190950: GO:0009059 macromolecule biosynthetic process
|
|
GS178461: GO:0009987 cellular process
|
|
GS193220: GO:0006082 organic acid metabolic process
|
|
GS136045: insulin dependent diabetes susceptibility 22 (Idd22, Published QTL Chr 8)
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS182834: GO:0005623 cell
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
|
|
GS190997: GO:0044281 small molecule metabolic process
|
|
GS199201: GO:0031224 intrinsic to membrane
|
|
GS178235: GO:1901071 glucosamine-containing compound metabolic process
|
|
GS135547: CD4 T cell subset 3 (Cd4ts3, Published QTL Chr 8)
|
|
GS135483: bone response to mechanical loading 3 (Brml3, Published QTL Chr 8)
|
|
GS173247: HP:0007957 Reduction of corneal clarity
|
|
GS199635: GO:0005622 intracellular
|
|
GS200263: GO:0006024 glycosaminoglycan biosynthetic process
|
|
GS193268: GO:0005575 cellular_component
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS175571: HP:0011492 Abnormality of corneal stroma
|
|
GS196943: GO:0008152 metabolic process
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS135840: femoral bone trait QTL 3 (Fbtq3, Published QTL Chr 8)
|
|
GS196941: GO:0008150 biological_process
|
|
GS135948: HDL QTL 16 (Hdlq16, Published QTL Chr 8)
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS167518: MP:0001312 abnormal cornea morphology
|
|
GS199634: GO:0005623 cell
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS124695: arsenic trioxide interacting genes (MeSH:C006632) in CTD
|
|
GS190713: GO:0016021 integral to membrane
|
|
GS201256: GO:0044422 organelle part
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS86420: Table S4: Cocaine Regulation of Dimethyl-K9 / K27 H3. [DRG]
provisional
|
|
GS185724: GO:0043436 oxoacid metabolic process
|
|
GS172843: HP:0000481 Abnormality of the cornea
|
|
GS187828: GO:0044272 sulfur compound biosynthetic process
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS136001: heterogeneity in eye lens protein photooxidation kinetics (Hlpx, Published QTL Chr 8)
|
|
GS170406: MP:0005543 corneal thinning
|
|
GS136802: tibia bone quality traits 2 (Tbqt2, Published QTL Chr 8)
|
|
GS191106: GO:0044464 cell part
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS201251: GO:0044424 intracellular part
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS201288: GO:0008146 sulfotransferase activity
|
|
GS187771: GO:1901566 organonitrogen compound biosynthetic process
|
|
GS171453: HP:0003674 Onset
|
|
GS129101: bone mineral density 39 (Bmd39 Published QTL Chr 8)
|
|
GS177061: GO:0006044 N-acetylglucosamine metabolic process
|
|
GS209234: GO:0006790 sulfur compound metabolic process
|
|
GS171657: HP:0000613 Photophobia
|
|
GS188446: GO:0000139 Golgi membrane
|
|
GS164448: MP:0005193 abnormal anterior eye segment morphology
|
|
GS205609: GO:0044431 Golgi apparatus part
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS136512: prion incubation time 3 (Pitm3, Published QTL Chr 8)
|
|
GS175835: HP:0007759 Opacification of the corneal stroma
|
|
GS184447: GO:0044424 intracellular part
|
|
GS121893: Vitamin E interacting genes (MeSH:D014810) in CTD
|
|
GS135717: despair 1 (Desp1, Published QTL Chr 8)
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS167527: MP:0005300 abnormal corneal stroma morphology
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS202555: GO:0043436 oxoacid metabolic process
|
|
GS135844: femoral cross-sectional area 2 (Fcsa2, Published QTL Chr 8)
|
|
GS124579: Selenium interacting genes (MeSH:D012643) in CTD
|
|
GS136369: obesity QTL 16 (Obq16, Published QTL Chr 8)
|
|
GS123340: Keratan Sulfate interacting genes (MeSH:D007632) in CTD
|
|
GS135482: bone response to mechanical loading 2 (Brml2, Published QTL Chr 8)
|
|
GS184484: GO:0008146 sulfotransferase activity
|
|
GS163971: MP:0002092 abnormal eye morphology
|
|
GS184257: GO:0042339 keratan sulfate metabolic process
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS180164: GO:0008150 biological_process
|
|
GS136300: mean platelet volume locus 2 (Mpvq2, Published QTL Chr 8)
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS209566: GO:0006040 amino sugar metabolic process
|
|
GS195036: GO:0031090 organelle membrane
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS135883: femur geometry 7 (Fmgty7, Published QTL Chr 8)
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS187769: GO:1901564 organonitrogen compound metabolic process
|
|
GS207858: GO:0009059 macromolecule biosynthetic process
|
|
GS208012: GO:0044464 cell part
|
|
GS136131: lithogenic gene 11 (Lith11, Published QTL Chr 8)
|
|
GS201252: GO:0044425 membrane part
|
|
GS136733: susceptibility to lung cancer 9 (Sluc9, Published QTL Chr 8)
|
|
GS210212: GO:0005575 cellular_component
|
|
GS204687: GO:0044272 sulfur compound biosynthetic process
|
|
GS194503: GO:1901137 carbohydrate derivative biosynthetic process
|
|
GS178284: GO:0031090 organelle membrane
|
|
GS201065: GO:0042339 keratan sulfate metabolic process
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS199922: GO:0005975 carbohydrate metabolic process
|
|
GS210163: GO:0006082 organic acid metabolic process
|
|
GS210234: GO:0018146 keratan sulfate biosynthetic process
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS191130: GO:0016782 transferase activity, transferring sulfur-containing groups
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS201075: GO:0005794 Golgi apparatus
|
|
GS174243: HP:0011495 Abnormality of corneal epithelium
|
|
GS203594: GO:0043226 organelle
|
|
GS200257: GO:0006022 aminoglycan metabolic process
|
|
GS196284: GO:0012505 endomembrane system
|
|
GS208734: GO:0016740 transferase activity
|
|
GS122199: poly-N-acetyllactosamine interacting genes (MeSH:C037199) in CTD
|
|
GS36086: Cerebellum Gene expression correlates of Activity in altered context in fear conditioning apparatus in Females BXD
|
|
GS193780: GO:0006044 N-acetylglucosamine metabolic process
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS208038: GO:0016782 transferase activity, transferring sulfur-containing groups
|
|
GS183461: GO:0006022 aminoglycan metabolic process
|
|
GS194985: GO:1901071 glucosamine-containing compound metabolic process
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS183467: GO:0006024 glycosaminoglycan biosynthetic process
|
|
GS190949: GO:0009058 biosynthetic process
|
|
GS136921: vertebral morphology and mechanical traits 9 (Vmmt9, Published QTL Chr 8)
|
|
GS175390: HP:0011007 Age of onset
|
|
GS186744: GO:0043226 organelle
|
|
GS124314: apple polyphenol extract interacting genes (MeSH:C526219) in CTD
|
|
GS206103: GO:0001517 N-acetylglucosamine 6-O-sulfotransferase activity
|
|
GS188750: GO:0044431 Golgi apparatus part
|
|
GS128597: Ethanol Induced Ataxia Chr#8
|
|
GS182835: GO:0005622 intracellular
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS194505: GO:1901135 carbohydrate derivative metabolic process
|
|
GS182404: GO:0031224 intrinsic to membrane
|
|
GS135513: "body weight, QTL 3" (Bwq3, Published QTL Chr 8)
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS135540: cerebellum weight 2 (Cbm2, Published QTL Chr 8)
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS194087: GO:0003674 molecular_function
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS205302: GO:0000139 Golgi membrane
|
|
GS165778: MP:0003092 decreased corneal stroma thickness
|
|
GS177356: GO:0003674 molecular_function
|
|
GS207615: GO:0016021 integral to membrane
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS136356: novelty/stress induced locomotor activation 7 (Nsila7, Published QTL Chr 8)
|
|
GS189235: GO:0001517 N-acetylglucosamine 6-O-sulfotransferase activity
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS184448: GO:0044425 membrane part
|
|
GS173080: HP:0000495 Recurrent corneal erosions
|
|
GS179519: GO:0012505 endomembrane system
|
|
GS180166: GO:0008152 metabolic process
|
|
GS176387: HP:0007856 Punctate opacification of the cornea
|
|
GS136313: non-HDL QTL 1 (Nhdlq1, Published QTL Chr 8)
|
|
GS191796: GO:0016740 transferase activity
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS193289: GO:0018146 keratan sulfate biosynthetic process
|
|
GS184267: GO:0005794 Golgi apparatus
|
|
GS135989: Hfe modifier 2 (Hfem2, Published QTL Chr 8)
|
|
GS204631: GO:1901566 organonitrogen compound biosynthetic process
|
|
GS183122: GO:0005975 carbohydrate metabolic process
|
|
GS174652: HP:0001131 Corneal dystrophy
|
|
GS200258: GO:0006023 aminoglycan biosynthetic process
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS136059: Immunoregulatory 1 (Im1, Published QTL Chr 8)
|
|
GS84206: METH responses for body temperature (Published QTL, Chr 8)
|
|
GS169531: MP:0005391 vision/eye phenotype
|
|
GS136068: immune response to AAV2 QTL 2 (Imraq2, Published QTL Chr 8)
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS135972: wound healing/regeneration 1 (Heal1, Published QTL Chr 8)
|
|
GS172354: HP:0004328 Abnormality of the anterior segment of the eye
|
|
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS135613: circulating hormone level QTL 5 (Chlq5, Published QTL Chr 8)
|
|
GS177766: GO:1901135 carbohydrate derivative metabolic process
|
|
GS190714: GO:0016020 membrane
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS207616: GO:0016020 membrane
|
|
GS195214: GO:0009987 cellular process
|
|
GS184452: GO:0044422 organelle part
|
|
GS192626: GO:0006040 amino sugar metabolic process
|
|
GS135850: food preference (Fdpref, Published QTL Chr 8)
|
|
GS177764: GO:1901137 carbohydrate derivative biosynthetic process
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS192298: GO:0006790 sulfur compound metabolic process
|
|
GS136920: vertebral morphology and mechanical traits 8 (Vmmt8, Published QTL Chr 8)
|
|
GS128577: Ethanol induced LORR Chr# 8
|
|
GS183462: GO:0006023 aminoglycan biosynthetic process
|
|
GS135886: forelimb polydactyly (Fpdty, Published QTL Chr 8)
|
|
GS175529: HP:0000001 All
|